Home > Financial Ratios > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
EV/Core EBITDA

    Back to All Ratios
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

ONESOURCE SPECIALTY PHARMA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023
   EV/Core EBITDA(x) 53.10-6.07-4.82

What is the latest EV/Core EBITDA ratio of ONESOURCE SPECIALTY PHARMA ?

The latest EV/Core EBITDA ratio of ONESOURCE SPECIALTY PHARMA is 53.10 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202553.10
Mar2024-6.07
Mar2023-4.82

How is EV/Core EBITDA of ONESOURCE SPECIALTY PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 53.1
Positive
Mar2024 -6.07
Negative
Mar2023 -4.82 -

Other Financial Ratios of ONESOURCE SPECIALTY PHARMA


Compare EV/Core EBITDA ratio of peers of ONESOURCE SPECIALTY PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA ₹15,422.3 Cr 1.6% 13.4% 3.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


ONESOURCE SPECIALTY PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA

1.6%

13.4%

3.3%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses